Cookson Peirce & Co’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-6,215
| Closed | -$389K | – | 230 |
|
|
2023
Q4 | $389K | Buy |
+6,215
| New | +$389K | 0.02% | 166 |
|
|
2022
Q3 | – | Sell |
-17,783
| Closed | -$1.08M | – | 192 |
|
|
2022
Q2 | $1.08M | Buy |
+17,783
| New | +$1.08M | 0.07% | 100 |
|
|
2021
Q4 | – | Sell |
-15,053
| Closed | -$1.69M | – | 211 |
|
|
2021
Q3 | $1.69M | Buy |
15,053
+1,726
| +13% | +$193K | 0.1% | 101 |
|
|
2021
Q2 | $2.16M | Buy |
+13,327
| New | +$2.16M | 0.13% | 95 |
|
|
2021
Q1 | – | Sell |
-17,183
| Closed | -$2.63M | – | 180 |
|
|
2020
Q4 | $2.63M | Buy |
17,183
+1,539
| +10% | +$236K | 0.18% | 70 |
|
|
2020
Q3 | $1.31M | Buy |
15,644
+4,446
| +40% | +$372K | 0.1% | 83 |
|
|
2020
Q2 | $823K | Buy |
11,198
+1,652
| +17% | +$121K | 0.08% | 81 |
|
|
2020
Q1 | $405K | Buy |
+9,546
| New | +$405K | 0.05% | 105 |
|
|
2019
Q3 | – | Sell |
-8,105
| Closed | -$382K | – | 139 |
|
|
2019
Q2 | $382K | Buy |
+8,105
| New | +$382K | 0.03% | 129 |
|
|
2019
Q1 | – | Sell |
-7,620
| Closed | -$218K | – | 147 |
|
|
2018
Q4 | $218K | Buy |
+7,620
| New | +$218K | 0.02% | 144 |
|